“Patients as Partners” by the Scleroderma Foundation

The Scleroderma Foundation announced the “Patients as Partners” program intended to help the scleroderma patient community partake with pharmaceutical and biotech companies working on clinical trial designs and other drug development initiatives for scleroderma and related conditions.

Learn more about ‘Patients as Partners’ here: http://bit.ly/24xwYvl

Learn more about scleroderma here: http://bit.ly/learnscleroderma